Bet. Works™ announced today that it has been granted one of the first concurrent Gaming Laboratories International GLI-33 / GLI-19 certifications for Sportsbook operations.
Bet.Works™ has successfully completed pre-compliance testing of its Sportsbook Platform against the “GLI-33: Event Wagering Systems” standard.
These standards offer a definitive roadmap regarding betting integrity and a way to move forward responsibly in the post Professional and Amateur Sports Protection Act (PASPA) era.
The US sports betting market is estimated by Morgan Stanley to be approximately $400 billion dollars being wagered annually by an estimated 44 million US citizens.
Bet.Works’ Founder/CEO David Wang said: “We are pleased to have completed this part of our business operation. GLI is the global leader in authentication of gaming technologies and it was a pleasure to work with them through this process.
“This GLI certification verifies that Bet.Works™ complies with GLI-19 and GLI-33 technical standards, thus allowing Bet.Works™ to pursue second phase product approvals with regulatory licensing jurisdictions that require their own proprietary product certification or jurisdictional / internal lab testing.
“We feel strongly that acquiring this certification will expedite our licensing process in many jurisdictions that will be legalizing sports betting in the United States and look forward to working with business partners and Regulators in that regard.”
Salim Adatia, GLI’s Vice President of iGaming Services was quick to point out the enormous value to obtaining the GLI certifications for the Bet.Works™ Sportsbook platform.
“GLI’s sports wagering team created the GLI-33 standard by compiling and integrating event wagering best practices from other regulated markets around the world.
“This established a clear and cohesive technical standard for sports wagering systems across multiple delivery channels including retail, self-service kiosks, in-venue mobile and internet.”
Mr. Adatia added: “The team at Bet.Works™ worked diligently and supported the testing process enthusiastically in order to acquire concurrent GLI-33 and GLI-19 approvals for their platform.”